Frankfurt - Delayed Quote EUR

MindBio Therapeutics Corp. (WF6.F)

0.0030
0.0000
(0.00%)
As of 3:29:02 PM GMT+2. Market Open.
Loading Chart for WF6.F
  • Previous Close 0.0030
  • Open 0.0034
  • Bid 0.0020 x --
  • Ask 0.0080 x --
  • Day's Range 0.0030 - 0.0034
  • 52 Week Range 0.0004 - 0.0372
  • Volume 39,253
  • Avg. Volume 5,659
  • Market Cap (intraday) 568,389
  • Beta (5Y Monthly) 0.13
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

MindBio Therapeutics Corp., together with its subsidiaries, operates as a clinical stage drug development company in Australasia. The company engages in researching, developing, and testing microdosing of psychedelic substances as a potential treatment for the management of various mental health conditions, such as depression, anxiety, chronic pain, cognitive impairment, post-traumatic stress disorder, panic disorder, and opiate addictions. It also establishes and executes research protocols through formal clinical trials that are facilitated via digital therapeutic platforms; and invests in research for developing treatments for depression, anxiety, PTSD and chronic pain. In addition, the company develops MB22001, which is in Phase 2 clinical trial, for the treatment of major depressive disorder, as well as existential distress, anxiety, and depression associated with advanced stage cancer; and wearable devices to collect biometric data in mental health patients taking psychedelic medicines. MindBio Therapeutics Corp. was incorporated in 2021 and is headquartered in Vancouver, Canada.

www.mindbiotherapeutics.com

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: WF6.F

View More

Performance Overview: WF6.F

Trailing total returns as of 6/10/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

WF6.F
0.00%
S&P/TSX Composite index (^GSPTSE)
7.11%

1-Year Return

WF6.F
88.28%
S&P/TSX Composite index (^GSPTSE)
19.49%

3-Year Return

WF6.F
96.67%
S&P/TSX Composite index (^GSPTSE)
30.06%

5-Year Return

WF6.F
96.67%
S&P/TSX Composite index (^GSPTSE)
67.95%

Compare To: WF6.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WF6.F

View More

Valuation Measures

Annual
As of 6/9/2025
  • Market Cap

    1.14M

  • Enterprise Value

    3.97M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    88.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -364.90%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    -630.65k

  • Net Income Avi to Common (ttm)

    -1.63M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.25k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -575.91k

Research Analysis: WF6.F

View More

Company Insights: WF6.F

Research Reports: WF6.F

View More